Immunology and autoimmune tests check how well your immune system is functioning. At Bids Chemist, these tests detect conditions where the body attacks itself, such as lupus or rheumatoid arthritis. Identifying issues early helps manage symptoms, prevent complications, and support your immune health with proper treatment and lifestyle adjustments.
This test measures 6-Thioguanine nucleotides (6-TGN) levels in the blood, which are active metabolites of thiopurine medications used to treat autoimmune conditions such as Crohn’s disease, ulcerative colitis, and certain leukemias. By monitoring 6-TGN levels, healthcare providers can assess whether the medication dose is effective while minimising the risk of side effects, such as liver toxicity or low blood cell counts. Patients benefit by ensuring their therapy is safe, tailored, and optimised for disease control. Regular monitoring allows early intervention if levels are too low or high, supporting long-term treatment success and reducing complications. This test is an essential tool in personalising treatment for immune and blood-related conditions.
This test identifies autoantibodies targeting the adrenal cortex, which can indicate autoimmune disorders such as Addison’s disease. The adrenal glands produce essential hormones including cortisol and aldosterone, which regulate metabolism, blood pressure, and stress responses. Blood is collected and analysed in the laboratory, and results are interpreted in combination with hormone levels and clinical symptoms such as fatigue, dizziness, low blood pressure, and weight loss. Early detection allows timely intervention with hormone replacement therapy, preventing serious complications such as adrenal crisis. Understanding adrenal autoantibody status enables healthcare providers to develop personalised monitoring and management plans for patients at risk of adrenal insufficiency, supports long-term health, and helps prevent complications by maintaining hormonal balance.
This test detects autoantibodies associated with vasculitis, an inflammatory condition affecting blood vessels and potentially multiple organs. Blood is drawn and analysed to confirm the presence of antibodies, guiding diagnosis, monitoring, and treatment planning. Early identification helps prevent organ damage, manage symptoms, and optimise patient outcomes. Understanding antibody status allows healthcare providers to implement timely interventions and track disease progression to improve quality of life.
This test detects antibodies specific to rheumatoid arthritis, helping healthcare providers diagnose early disease and implement timely treatment. Blood is drawn and interpreted alongside clinical symptoms and other markers of inflammation. Early detection allows for interventions that reduce joint damage, improve mobility, and enhance quality of life. Monitoring antibody status helps guide therapy selection and assess disease progression, supporting effective management of autoimmune conditions.
This test detects antibodies to double-stranded DNA, commonly associated with systemic lupus erythematosus (SLE). Blood is collected, and results help diagnose, monitor disease activity, and guide treatment decisions. Early detection allows healthcare providers to prevent organ damage, manage flares effectively, and optimise long-term outcomes. Understanding antibody status supports personalised care, proactive monitoring, and tailored therapy for autoimmune disease management.
This test measures antinuclear antibodies (ANA), which indicate autoimmune activity and help diagnose conditions such as lupus, Sjögren’s syndrome, or scleroderma. Blood is drawn and results guide diagnosis, monitoring, and management. Early detection supports timely treatment to prevent organ damage, control symptoms, and improve long-term outcomes. Understanding ANA status helps healthcare providers tailor therapy, monitor disease progression, and implement preventive strategies for autoimmune disorders. Patients benefit from personalised care and informed decision-making regarding their autoimmune health.
This test evaluates a broad autoantibody profile to detect autoimmune activity affecting multiple organs. Blood is collected and analysed to identify markers associated with conditions such as lupus, vasculitis, or systemic autoimmune disease. Results help guide diagnosis, monitoring, and treatment planning. Early identification allows healthcare providers to manage symptoms effectively, prevent organ damage, and develop personalised therapy strategies. Patients benefit from comprehensive insight into immune system function and early intervention to maintain long-term health.
This test measures C1 esterase inhibitor levels and function, important for regulating inflammation and preventing angioedema. Blood is collected, and results help diagnose hereditary or acquired angioedema, which can cause swelling in various tissues, including the airway. Early detection allows healthcare providers to provide timely treatment, prophylactic measures, and personalised management plans. Patients benefit from knowing their C1 esterase status to prevent complications, manage symptoms, and improve quality of life.
This test measures C1q binding immune complexes, which are part of the immune system’s response to infection or autoimmune disease. Blood is collected and analysed to detect abnormal immune activity. Elevated levels may indicate autoimmune conditions, inflammation, or kidney involvement. Results help healthcare providers diagnose, monitor, and manage systemic autoimmune or inflammatory disorders. Patients benefit from understanding immune system activity to guide treatment, prevent complications, and optimise long-term health.
This test measures C4 complement, another essential protein in the immune system. Blood is collected and analysed to assess immune function. Abnormal C4 levels can indicate autoimmune disorders, infections, or liver disease. Results guide healthcare providers in diagnosis, treatment, and monitoring of immune-related conditions. Patients benefit from understanding their complement levels, allowing early interventions and better long-term immune health management.
This test detects cardiolipin antibodies (IgG and IgM), which are associated with autoimmune conditions such as antiphospholipid syndrome. Blood is collected and analysed to assess the presence of these antibodies. Elevated levels can increase the risk of blood clots, recurrent pregnancy loss, or cardiovascular events. Early detection allows healthcare providers to implement preventive strategies, lifestyle interventions, or medication, reducing potential complications. Patients benefit from understanding their immune status and managing long-term health proactively.
This test measures CD56, a protein expressed on natural killer cells and certain neural or hematologic cells. Blood is drawn and analysed to evaluate immune function, hematologic conditions, or neural disorders. Abnormal levels can indicate immune deficiencies, certain cancers, or autoimmune diseases. Understanding CD56 status helps healthcare providers monitor disease progression, guide treatment, and optimise immune health. Patients benefit from insight into immune function and early intervention strategies.
This test measures antibodies and other markers related to gluten sensitivity and coeliac disease. Blood is collected and analysed to detect immune responses to gluten. Elevated results may indicate coeliac disease, non-coeliac gluten sensitivity, or other autoimmune conditions. Early detection allows healthcare providers to recommend dietary modifications, nutritional support, and ongoing monitoring. Patients benefit by reducing symptoms, preventing complications, and improving overall gastrointestinal and metabolic health through proactive management.
This test measures complement C1q, a protein involved in immune response and inflammation. Blood is collected and analysed to assess immune function and detect potential autoimmune activity. Abnormal C1q levels may indicate lupus, vasculitis, or other systemic inflammatory conditions. Early detection enables healthcare providers to monitor disease progression, guide treatment, and prevent complications. Patients benefit from insight into immune health and proactive management strategies for long-term wellness.
This test measures complement C2, another essential immune protein that participates in pathogen defense. Blood is drawn and analysed to detect deficiencies or autoimmune activity. Abnormal results can indicate increased infection risk, inflammatory conditions, or systemic autoimmune disease. Understanding complement C2 levels helps healthcare providers guide treatment, monitor immune function, and implement preventive measures. Patients benefit from informed decisions regarding infection prevention and long-term immune health management.
This test detects extractable nuclear antibodies (ENA) including nRNP, Sm, Ro, La, Jo1, and Scl70, which are associated with autoimmune diseases such as lupus, scleroderma, and myositis. Blood is drawn and analysed to help diagnose, monitor, and guide treatment. Early detection allows healthcare providers to prevent organ damage, implement therapy, and improve long-term outcomes. Patients benefit by understanding immune status and managing autoimmune conditions proactively.
This test detects gastric parietal autoantibodies, which may indicate autoimmune gastritis or risk of pernicious anemia. Blood is collected and analysed to identify immune-mediated damage to stomach cells, affecting vitamin B12 absorption. Early detection allows healthcare providers to recommend supplementation, monitor nutritional status, and prevent long-term complications such as anemia or neurological symptoms. Patients benefit by maintaining digestive and metabolic health, optimising nutrient absorption, and preventing chronic disease.
The Glomerular Basement Membrane (GBM) Antibody test detects antibodies that attack the thin membranes in your kidneys. These antibodies are often associated with autoimmune kidney diseases such as Goodpasture’s syndrome, which can lead to kidney damage and bleeding in the lungs. The test is usually ordered when patients show symptoms like blood in the urine, swelling, or unexplained kidney function changes. A blood sample is required, and results are interpreted in combination with other kidney function tests and clinical symptoms. Early detection helps healthcare providers diagnose autoimmune kidney disease promptly, initiate appropriate treatment, and prevent further kidney injury. Understanding the presence of GBM antibodies can help patients participate in their treatment planning and monitor disease progression effectively.
The GAD 65 Antibody test detects autoantibodies that target pancreatic beta cells, which produce insulin. It is mainly used to help diagnose type 1 diabetes, especially in patients with high blood sugar but no typical risk factors for type 2 diabetes. Early identification of autoimmune diabetes can guide treatment choices and help prevent complications. A blood sample is required, and the results are interpreted alongside other diabetes markers, such as glucose and HbA1c. Understanding the presence of these antibodies empowers patients to monitor their condition, manage blood sugar effectively, and make informed decisions about lifestyle or insulin therapy.
Measures subclasses of Immunoglobulin G (IgG1-4), important for assessing immune function and susceptibility to infections. Helps diagnose immune deficiencies or autoimmune conditions. Blood is drawn, and results guide treatment plans, immunization strategies, and monitoring of immune health.
Measures IgA, an antibody critical for mucosal immunity. Low or high levels may indicate immune deficiency, chronic infections, or autoimmune disease. Blood is drawn, and results help guide diagnosis, monitoring, and preventive care.
Measures IgG antibodies, important for long-term immunity against infections. Abnormal levels can indicate immune deficiency or chronic infections. Blood is drawn, and results guide diagnosis, treatment, and preventive measures.
Comprehensive panel assessing IgG, IgM, and IgA antibodies, providing a full picture of immune function. Useful in detecting immune deficiencies, autoimmune disorders, or chronic infections. Blood is drawn, and results guide clinical decisions and patient management.
Detects antibodies against intrinsic factor, a protein required for vitamin B12 absorption. Positive results may indicate pernicious anemia or autoimmune gastritis, which can lead to fatigue, weakness, or neurological symptoms. Blood is drawn, and results guide vitamin B12 supplementation and treatment. Early detection helps prevent long-term complications such as nerve damage.
This test detects antibodies against pancreatic islet cells, which can indicate autoimmune activity against insulin-producing cells. Blood is drawn and analysed to assess risk or presence of type 1 diabetes. Early detection allows healthcare providers to monitor blood sugar, initiate appropriate therapy, and implement preventive measures. Patients benefit by understanding autoimmune risk, maintaining glucose control, and protecting long-term metabolic health. Timely identification supports early intervention, reducing complications associated with diabetes onset.
Detects autoantibodies targeting liver and kidney cells, often associated with autoimmune hepatitis or related conditions. Blood is drawn and analysed, helping diagnose autoimmune liver disease and monitor disease activity. Results guide treatment decisions and early interventions to prevent organ damage.
This panel detects antibodies that increase blood clot risk, associated with antiphospholipid syndrome or lupus. Helps explain recurrent thrombosis or pregnancy complications. Blood is collected and results guide anticoagulant therapy and risk management. Early detection allows preventive strategies to reduce clotting and associated health risks.
Detects autoantibodies that increase blood clot risk. Helps identify patients at risk of thrombosis or pregnancy complications. Blood is drawn, and results are interpreted with clinical history. Early detection allows preventive treatment and monitoring.
Measures specific types of lymphocytes, including T-helper (CD4) and T-cytotoxic (CD8) cells, providing insight into immune system function. Useful in immunodeficiency, HIV monitoring, or autoimmune disorders. Blood is drawn, and results guide treatment and immune health assessment. Understanding lymphocyte subsets helps manage infection risk, monitor immune response, and inform clinical decisions.
This test detects antibodies targeting mitochondrial proteins, which may indicate autoimmune or inflammatory disorders. Blood is collected and analysed to evaluate immune activity affecting cellular energy production. Abnormal results can help healthcare providers diagnose autoimmune conditions, monitor progression, and guide treatment. Patients benefit by identifying immune-mediated disease early, managing symptoms, and maintaining long-term organ and metabolic health. Comprehensive testing ensures targeted interventions and improved long-term wellness.
This test detects antibodies against myeloperoxidase, an enzyme linked to certain autoimmune disorders such as vasculitis. Blood is collected and analysed to evaluate immune activity. Abnormal results help healthcare providers diagnose autoimmune disease, monitor progression, and guide treatment. Patients benefit by identifying immune dysfunction early, managing symptoms, and protecting long-term organ and metabolic health through targeted care.
This panel evaluates multiple markers associated with autoimmune or inflammatory muscle disease, collectively known as myositis. Blood is collected and analysed to detect immune-mediated muscle damage, inflammation, and autoantibodies. Early detection allows healthcare providers to guide therapy, monitor progression, and prevent complications such as muscle weakness or organ involvement. Patients benefit by understanding muscle health, receiving targeted interventions, and maintaining long-term physical function and overall wellness.
This assay evaluates natural killer (NK) cell activity, which is crucial for the body’s immune defense against infected or malignant cells. Blood is collected and analysed to assess the cytotoxic activity of NK cells. Abnormal results may indicate immunodeficiency, chronic infection, or increased cancer risk. Healthcare providers use this information to guide immune monitoring, therapeutic interventions, and preventive strategies. Patients benefit by understanding immune competence, detecting early immune dysfunction, and implementing personalised care plans. Monitoring NK cell function supports proactive management of potential health risks, optimising immune response, and maintaining long-term wellness. Timely testing enables intervention before complications develop.
This test detects ovarian autoantibodies, which may indicate autoimmune-related ovarian dysfunction or infertility. Blood is collected and analysed to identify immune activity targeting ovarian tissue. Abnormal results help healthcare providers guide fertility counseling, hormone therapy, or monitoring interventions. Patients benefit by understanding reproductive health risks, receiving early interventions, and optimising ovarian function and long-term fertility outcomes. Early detection supports personalised care, preventive strategies, and overall wellness.
This test detects antibodies against proteinase 3, an enzyme linked to autoimmune disorders such as vasculitis. Blood is collected and analysed to evaluate immune activity and identify potential autoimmune disease. Early detection helps healthcare providers guide therapy, monitor disease progression, and prevent organ damage. Patients benefit by understanding immune function, managing symptoms proactively, and protecting long-term health. Timely assessment enables targeted treatment, reducing complications and supporting overall wellness.
This test measures rheumatoid factor using a latex method, detecting antibodies associated with autoimmune joint disorders like rheumatoid arthritis. Blood is collected and analysed to evaluate autoimmune activity and support diagnosis. Abnormal results guide healthcare providers in therapy planning, monitoring disease progression, and preventive care. Patients benefit by identifying autoimmune risks, receiving early intervention, and protecting joint health. Timely testing supports proactive management and long-term wellness.
This test detects salivary duct antibodies, which may indicate autoimmune or inflammatory conditions affecting salivary glands, such as Sjögren’s syndrome. Blood is collected and analysed to assess immune activity. Abnormal results help healthcare providers diagnose autoimmune disorders, guide treatment, and monitor disease progression. Patients benefit by understanding glandular and immune health, managing symptoms proactively, and protecting long-term organ function. Early detection enables timely intervention and supports overall wellness.
This test detects smooth muscle antibodies, which may indicate autoimmune liver disease or systemic autoimmune disorders. Blood is collected and analysed to evaluate immune activity. Abnormal results help healthcare providers diagnose autoimmune conditions, guide therapy, and monitor disease progression. Patients benefit by identifying autoimmune risk early, managing symptoms, and protecting long-term organ health. Timely assessment supports targeted interventions and overall wellness.
This test measures tissue transglutaminase IgA antibodies to screen for coeliac disease. Blood is collected and analysed to detect autoimmune activity triggered by gluten ingestion. Abnormal results suggest coeliac disease, which can cause gastrointestinal symptoms, nutrient deficiencies, and systemic complications. Healthcare providers use results to confirm diagnosis, guide dietary interventions, and monitor compliance. Patients benefit by identifying gluten intolerance early, implementing dietary modifications, and preventing long-term complications. Timely assessment supports digestive health, nutrient absorption, and overall wellness.
